Bempedoic acid/Ezetimibe Prescribing at BALSALL COMMON & MERIDEN GROUP PRACTICE
Lipid-regulating drugs | Cardiovascular System
Items (12m)
100
Total Quantity
3,920
NHS Cost
£7.4K
vs National Avg
+63.8%
BALSALL COMMON & MERIDEN GROUP PRACTICE prescribed 100 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £7,375 to the NHS. This is 63.8% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jul 2026
4
Jul 2026
6
Jul 2026
4
Jul 2026
7
Jul 2026
8
Jul 2026
8
Jul 2026
9
Jul 2026
11
Jul 2026
8
Jul 2026
10
Jul 2026
11
Jul 2026
14
Prescribing Details
| Total Items | 100 |
|---|---|
| Total Quantity | 3,920 |
| Total NHS Cost | £7,375 |
| Presentations | 2 different forms |
| vs National Average | +63.8% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 100 items |
|---|---|
| National average per practice | 61 items |
| Difference | +63.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.